Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Journal of Clinical Oncology (JCO)
Published October 8, 2026
Prognostic Impact of Telomere Maintenance Mechanisms in Neuroblastoma.
October 9, 2026
Medspoke
Medspoke
Journal of Clinical Oncology (JCO)
Published October 8, 2026
00:00
--:--
RINGSIDE Phase II Study of Varegacestat for Treatment of Desmoid Tumors: A Randomized Dose-Findin...
October 9, 2026
Share
RINGSIDE Phase II Study of Varegacestat for Treatment of Desmoid Tumors: A Randomized Dose-Finding Clinical Trial.
https://www.medspoke.co/channel_journal?id=686&tap_id=15296
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Annals of Oncology
Published October 8, 2026
Sofetabart mipitecan, an antibody drug conjugate targeting folate receptor alpha, in high grade o...
October 9, 2026
Why are you reporting this TALK?
